Antibody blockade of CD147 substantially attenuates lung susceptibility to bacterial infection and lung leukocyte infiltration and thereby ameliorates stroke-associated pneumonia (SAP) and lung histological damage after stroke. Here, BSG is linked to bacterial infectious disease.